U.S. flag

An official website of the United States government

Display Settings:

Items per page

PMC Full-Text Search Results

Items: 7

1.
Figure 4.

Figure 4. From: Vitamin C protects HL60 and U266 cells from arsenic toxicity.

Intracellular AA (iAA) protects HL60 and U266 cells depleted from GSH and treated with As2O3. As2O3 toxicity in HL60 (A) and U266 (D) cells with (□) or without (▪) GSH. Cell viability (B,E) and colony formation (C,F) of HL60 and U266 cells depleted of GSH, loaded with vitamin C, and treated with 1 μMAs2O3. Cell viability was determined 48 hours after treatment. (A-F) Data are expressed as the mean ± SD of 3 independent experiments.

Nicos Karasavvas, et al. Blood. 2005 May 15;105(10):4004-4012.
2.
Figure 2.

Figure 2. From: Vitamin C protects HL60 and U266 cells from arsenic toxicity.

As2O3 is cytotoxic to HL60 and U266 cells. HL60 (A) and U266 (C) cells were treated with 1, 2, 3, 5, and 10 μMAs2O3 for 24 (○) and 48 (•) hours and viability was determined by trypan blue exclusion. Cloning efficiency of HL60 (B) and U266 (D) cells treated with 1 to 3 μM As2O3 or were left untreated. (A-D) Data are expressed as the mean ± SD of 3 independent experiments.

Nicos Karasavvas, et al. Blood. 2005 May 15;105(10):4004-4012.
3.
Figure 1.

Figure 1. From: Vitamin C protects HL60 and U266 cells from arsenic toxicity.

Transport and accumulation of vitamin C in HL60 and U266 cells. HL60 (A) and U266 (B) cells were incubated for the time indicated with 250 μM dehydroascorbic acid (DHA; ○) or ascorbic acid (AA; •) at room temperature. Intracellular accumulation of vitamin C in HL60 and U266 cells treated with DHA for 60 minutes at 37°C (A-B insets). (C) Inhibition of DHA transport in U266 cells treated with cytochalasin E (Cyt E; ○) and B (•). (A-C) Data are expressed as the mean ± SD of 3 independent experiments. iAA indicates intracellular AA.

Nicos Karasavvas, et al. Blood. 2005 May 15;105(10):4004-4012.
4.
Figure 3.

Figure 3. From: Vitamin C protects HL60 and U266 cells from arsenic toxicity.

Intracellular AA (iAA) protects HL60, U266, and RPMI-8226 cells from As2O3 cytotoxicity. Cell viability of HL60 (A) and U266 (D) cells loaded with vitamin C using DHA and exposed to As2O3 for 48 hours. Cloning efficiency of HL60 (B) and U266 (E) cells loaded with vitamin C and treated with 2 and 1 μMAs2O3, respectively. (C) HL60 cells were loaded with 4 mM iAA, treated with 3 μMAs2O3 for 24 or 48 hours, and apoptotic cells were stained using annexin V–FITC assay (left panel) or a TUNEL assay (right panel), respectively. (F) Cell viability of RPMI-8226 cells loaded with 4 mM AA and exposed to 1 μMAs2O3 for 48 hours. (A-F) Data are expressed as the mean ± SD of 3 independent experiments.

Nicos Karasavvas, et al. Blood. 2005 May 15;105(10):4004-4012.
5.
Figure 7.

Figure 7. From: Vitamin C protects HL60 and U266 cells from arsenic toxicity.

AA does not generate H2O2 in human plasma and the generation of H2O2 in plasma is dependent on the presence of free transition metal ions. Incubation of freshly isolated human plasma with increasing concentrations of AA. (A) The amount of H2O2 generated was determined by Amplex red. As a positive control, 100 μM AA was incubated in IMDM (last bar). (B) The generation of H2O2 was determined in human plasma incubated with 100 μM AA and increasing concentrations of CuCl2. (A-B) Experiments were performed in triplicate and are expressed as the mean ± SD of 2 independent experiments.

Nicos Karasavvas, et al. Blood. 2005 May 15;105(10):4004-4012.
6.
Figure 6.

Figure 6. From: Vitamin C protects HL60 and U266 cells from arsenic toxicity.

AA generates H2O2 in a cell-free system that is dependent on the presence of free transition metal ions. (A) Different concentrations of AA (○) and DHA (•) were incubated in IMDM for 1 hour at 37°C and H2O2 was determined by Amplex red. (B) The generation of H2O2 by 1 mM AA in IMDM in the presence or absence of 500 U/mL catalase. (C) Generation of H2O2 by 100 μM of AA or 10 μM CuCl2 in IMDM and increasing concentrations of DMP. (D) Generation of H2O2 by 50 μM of AA and increasing concentrations of As2O3 or 10 μM CuCl2 in 50 mM sodium phosphate buffer (pH 7.4). (A-D) Experiments were performed in triplicate and are expressed as the mean ± SD of 2 independent experiments.

Nicos Karasavvas, et al. Blood. 2005 May 15;105(10):4004-4012.
7.
Figure 5.

Figure 5. From: Vitamin C protects HL60 and U266 cells from arsenic toxicity.

Extracellular ascorbic acid generates ROSs and augments the cytotoxicity of As2O3. Cell viability of HL60 (A) and U266 cells (B) treated with 1, 2, 3, and 5 μMAs2O3 with (▪) or without (□) 100 μM extracellular ascorbic acid for 48 hours. (C, left) Annexin V (FL1) and PI (FL3) flow cytometry analysis of apoptotic HL60 cells treated with AA or DHA for 20 hours. (Right) Percentage of apoptotic cells after treatment with either AA, DHA, As2O3, or the combination of DHA and As2O3.NT indicates cells not treated. (D) Cell viability of HL60 cells containing (•) or depleted of (○) GSH and treated with increasing concentrations of ascorbic acid in culture media. Cell viability was determined 48 hours after treatment. (E) Production of ROSs in HL60 cells loaded with vitamin C using DHA (•) and in cells where ascorbic acid was added in culture media (○). Data are expressed as the mean ± SD of 3 (A-B) and 2 (C-E) independent experiments.

Nicos Karasavvas, et al. Blood. 2005 May 15;105(10):4004-4012.

Display Settings:

Items per page

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center